Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDrax Regulatory News (DRX)

Share Price Information for Drax (DRX)

Share Price is delayed by 15 minutes
Get Live Data
760.50    7.50 (1.00%)
Bid:
759.50
Ask:
760.50
Spread: 1.00 (0.132%)
Market Cap: £2.56b
DRX Live PriceLast checked at - London Stock Exchange

Intraday Drax Share Chart

Offer Lapsed

30 May 2025 07:00

RNS Number : 6813K
Drax Group PLC
30 May 2025
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION

 

FOR IMMEDIATE RELEASE

 

 

30 May 2025

 

 

DRAX BESS HOLDCO LIMITED ("DRAX BIDCO")

 

Lapse of Drax Bidco's offer for HEIT

Further to the announcement made by Drax Bidco, a wholly-owned subsidiary undertaking of Drax Group plc, on 20 May 2025, Drax Bidco today confirms that its cash offer for the entire issued share capital of HEIT (the "Acquisition" or the "Drax Offer") has lapsed.

On 25 March 2025, the boards of directors of Drax Bidco and HEIT made an announcement pursuant to Rule 2.7 of the Code that they had reached agreement on the terms of the Drax Offer, to be implemented by way of a court-sanctioned scheme of arrangement under Part 26 of the Companies Act 2006 (the "Drax Scheme").

The Drax Scheme was conditional, amongst other things, on Drax Bidco's Court Meeting being held on or before the 22nd day after 7 May 2025, being the originally expected date of the Court Meeting (or such later date as may be agreed by Drax Bidco and HEIT with the consent of the Panel and, if required that the Court may allow) (the "Mini Long Stop Date"). No such later date was agreed between Drax Bidco and HEIT and the Mini Long Stop Date therefore was 29 May 2025.

Condition 2(a)(ii), as set out in the Drax Scheme, was not satisfied on or before 29 May 2025. Drax Bidco has invoked the Mini Long Stop Date condition of the Drax Scheme and, as such, the Drax Scheme has lapsed, with effect from this announcement.

This announcement should be read in conjunction with the scheme document published or otherwise made available to HEIT Shareholders on 15 April 2025 (the "Scheme Document"). Capitalised terms in this announcement, unless otherwise defined have the same meanings as set out in Part X of the Scheme Document.

 

Enquiries:

 

Drax and Drax Bidco

 

Enquiries:

Drax Investor Relations:

Mark Strafford

mark.strafford@drax.com

+44 (0) 7730 763 949

 

Chris Simpson

Chris.Simpson@drax.com

+44 (0) 7923 257 815

 

Media:

Drax External Communications:

Chris Mostyn

Chris.Mostyn@drax.com

+44 (0) 7743 963 483

 

J.P. Morgan Cazenove (Financial Adviser and Corporate Broker to Drax and Drax Bidco)

+44 (0) 2034 938 000

Robert Constant

James Robinson

Alia Malik

Rupert Budge

Edward Hatter

 

Important notices

 

J.P. Morgan Securities plc, which conducts its UK investment banking business as J.P. Morgan Cazenove ("J.P. Morgan Cazenove"), is authorised in the United Kingdom by the PRA and regulated in the United Kingdom by the PRA and the FCA. J.P. Morgan Cazenove is acting as financial adviser exclusively for Drax Bidco and Drax and no one else in connection with the matters set out in this announcement and will not regard any other person as its client in relation to the matters in this announcement and will not be responsible to anyone other than Drax Bidco and Drax for providing the protections afforded to clients of J.P. Morgan Cazenove or its affiliates, nor for providing advice in relation to any matter referred to herein.

 

Further information

 

This announcement is for information purposes only and is not intended to and does not constitute, or form part of, an offer to sell or an invitation to purchase any securities or the solicitation of an offer to buy, otherwise acquire, subscribe for, sell or otherwise dispose of any securities, pursuant to the Acquisition or otherwise, nor shall there be any purchase, sale, issuance or exchange of securities or such solicitation in any jurisdiction in which such offer, invitation, solicitation, purchase, sale, issuance or exchange is unlawful.

 

This announcement has been prepared for the purpose of complying with English law, the Code, and the Disclosure Guidance and Transparency Rules, and the information disclosed may not be the same as that which would have been disclosed if this announcement had been prepared in accordance with the laws of jurisdictions outside England and Wales. The Acquisition will be subject to the applicable requirements of the Code, the Panel, the London Stock Exchange and the Financial Conduct Authority.

 

This announcement does not constitute a prospectus or prospectus exempted document.

The release, publication or distribution of this announcement in or into certain jurisdictions other than the United Kingdom may be restricted by law. Persons who are not resident in the United Kingdom or who are subject to other jurisdictions should inform themselves of, and observe, any applicable requirements.

If you are in any doubt about the contents of this announcement or the action you should take, you are recommended to seek your own independent financial advice immediately from your stockbroker, bank manager, solicitor or independent financial adviser duly authorised under the Financial Services and Markets Act 2000 (as amended) if you are resident in the United Kingdom or, if not, from another appropriate authorised independent financial adviser.

 

Publication on website and availability of hard copies

 

A copy of this announcement will be made available, free of charge, subject to certain restrictions relating to persons resident in Restricted Jurisdictions, on Drax's website at www.drax.com/investors/offer. For the avoidance of doubt, the contents of this website is not incorporated into and do not form part of this announcement.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OLABLGDUGDDDGUC
Date   Source Headline
25th Mar 20248:45 amRNSAdditional Listing
22nd Mar 202410:54 amRNSHolding(s) in Company
21st Mar 20248:00 amRNSMailing of Annual Report and Notice of AGM
18th Mar 20242:04 pmRNSHolding(s) in Company
18th Mar 202410:30 amRNSDirector/PDMR Shareholding
15th Mar 20242:51 pmRNSHolding(s) in Company
14th Mar 20241:37 pmRNSHolding(s) in Company
11th Mar 202412:26 pmRNSHolding(s) in Company
8th Mar 20244:07 pmRNSHolding(s) in Company
6th Mar 20242:46 pmRNSHolding(s) in Company
4th Mar 20243:35 pmRNSTotal Voting Rights
4th Mar 20243:18 pmRNSHolding(s) in Company
1st Mar 20242:38 pmRNSHolding(s) in Company
29th Feb 20247:04 amRNSNon-Executive Director standing down
29th Feb 20247:00 amRNSAnnual Financial Report
28th Feb 20247:00 amRNSCapacity Market Agreements
27th Feb 20249:20 amRNSHolding(s) in Company
23rd Feb 20244:32 pmRNSHolding(s) in Company
22nd Feb 202412:46 pmRNSNotice of Results
21st Feb 20249:32 amRNSHolding(s) in Company
15th Feb 202410:51 amRNSHolding(s) in Company
13th Feb 202412:47 pmRNSHolding(s) in Company
7th Feb 202410:32 amRNSHolding(s) in Company
1st Feb 202411:56 amRNSTotal Voting Rights
31st Jan 20243:16 pmRNSHolding(s) in Company
30th Jan 20242:15 pmRNSHolding(s) in Company
30th Jan 20248:45 amRNSAdditional Listing
29th Jan 20243:02 pmRNSHolding(s) in Company
25th Jan 20249:37 amRNSHolding(s) in Company
23rd Jan 20243:43 pmRNSHolding(s) in Company
18th Jan 202411:54 amRNSBridging Mechanism Consultation
16th Jan 20249:25 amRNSHolding(s) in Company
12th Jan 20243:29 pmRNSHolding(s) in Company
10th Jan 20241:22 pmRNSHolding(s) in Company
2nd Jan 202412:50 pmRNSTotal Voting Rights
27th Dec 20234:59 pmRNSHolding(s) in Company
20th Dec 20231:13 pmRNSDevelopment of UK CCS and BECCS business model
18th Dec 20238:45 amRNSAdditional Listing
5th Dec 20234:10 pmRNSTotal Voting Rights
5th Dec 20237:00 amRNSTrading Update
30th Nov 202311:03 amRNSHolding(s) in Company
29th Nov 20233:28 pmRNSHolding(s) in Company
27th Nov 20234:32 pmRNSHolding(s) in Company
13th Nov 202312:10 pmRNSHolding(s) in Company
8th Nov 20234:17 pmRNSHolding(s) in Company
2nd Nov 202311:42 amRNSHolding(s) in Company
1st Nov 20239:42 amRNSTotal Voting Rights
30th Oct 20238:30 amRNSDirector/PDMR Shareholding
27th Oct 20232:21 pmRNSHolding(s) in Company
24th Oct 20234:53 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.